FIELD: chemistry.
SUBSTANCE: invention pertains to new compounds with general formula (I) 
, and their salts used in pharmacology, and their hydra as well as others, where W represents 
or 
and R3, R7, R16, R17, R20, R21 and R21 are identical or different and each of them represents a hydrogen atom or assumes other values, given in the formula of invention. The invention also relates to pharmaceutical compositions and medicinal preparations based on these compounds, cultures, used for obtaining them, methods of inhibition and treatment and use.
EFFECT: formula (I) can be used as medicinal preparations for curing solid malignant tumours.
43 cl, 4 tbl, 60 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MACROCYCLIC COMPOUNDS, MEDICINAL AGENTS BASED ON THEM AND THEIR USE | 2003 |
|
RU2347784C2 |
| BENZOPIPERIDINE DERIVATIVES, BICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1992 |
|
RU2142945C1 |
| ANTITUMOR AGENT | 2018 |
|
RU2770824C2 |
| SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
| 14,17-C-BRIDGE STEROIDS AND PHARMACEUTICAL PREPARATION | 1995 |
|
RU2169153C2 |
| SULPHONAMIDE COMPOUND OR SALT THEREOF | 2017 |
|
RU2732572C2 |
| PYRAZOLE COMPOUNDS HAVING A THERAPEUTIC EFFECT ON MULTIPLE MYELOMA | 2011 |
|
RU2583430C2 |
| PROGESTERONE RECEPTOR MODULATORS | 2005 |
|
RU2381232C2 |
| SPIRO OXINDOLE MDM2 ANTAGONISTS | 2010 |
|
RU2553269C2 |
| ANALOGUES OF VITAMIN D, COMPOSITIONS CONTAINING INDICATED ANALOGUES AND THEIR USING | 2003 |
|
RU2320644C2 |
